Clinical, laboratory, and pacing predictors of CRT response

Journal of Cardiovascular Translational Research

Volumn 5, Issue 2, 2012, Pages 196-212

  Kandala, Jagdesh ^a   Altman, Robert K ^a   Park, Mi Young ^a   Singh, Jagmeet P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardiac resynchronization therapy; Congestive heart failure; Response predictors

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; COLLAGEN; COLLAGEN TYPE 1 TELOPEPTIDASE; CREATININE; GALACTIN 3; HEMOGLOBIN; INSULIN; INTERSTITIAL COLLAGENASE; PEPTIDASE; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROCOLLAGEN TYPE 3; PROLACTIN; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL EXAMINATION; COMORBIDITY; CONSENSUS DEVELOPMENT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE SIZE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HEART PACING; HEART PERFORMANCE; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE CONDUCTION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMAGE ANALYSIS; LABORATORY TEST; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX DIFFERENCE; SYSTOLIC HEART FAILURE; TISSUE DOPPLER IMAGING; TREATMENT RESPONSE;

CARDIAC RESYNCHRONIZATION THERAPY; ELECTROCARDIOGRAPHY; HEART FAILURE; HEART VENTRICLES; HUMANS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84866094080     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9352-0     Document Type: Review

References (141)

1. Birnie, D., et al. (2012). Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy. Journal of Nuclear Cardiology, 19(1), 73-83.
2. Epstein, A. E., et al. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 51(21), e1-e62.
3. Pires, L. A., et al. (2006). Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: Results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. American Heart Journal, 151 (4), 837-843.
4. McAlister, F. A., et al. (2007). Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: A systematic review. Journal of the American Medical Association, 297(22), 2502-2514. (Pubitemid 46953404)
5. Birnie, D. H.,&Tang, A. S. (2006). The problem of non-response to cardiac resynchronization therapy. Current Opinion in Cardiology, 21(1), 20-26. (Pubitemid 43194328)
6. Moss, A. J., et al. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. The New England Journal of Medicine, 361(14), 1329-1338.
7. Abraham, W. T. (2003). Cardiac resynchronization therapy: A review of clinical trials and criteria for identifying the appropriate patient. Reviews in Cardiovascular Medicine, 4(Suppl 2), S30- S37. (Pubitemid 36701295)
8. Bleeker, G. B., et al. (2006). Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. The American Journal of Cardiology, 97(2), 260-263. (Pubitemid 43139248)
9. Young, J. B., et al. (2003). Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. Journal of the American Medical Association, 289(20), 2685-2694. (Pubitemid 37430139)
10. Sutton, M. G., et al. (2006). Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: Quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation, 113(2), 266-272.
11. Cowburn, P. J., et al. (2005). Cardiac resynchronization therapy: An option for inotrope-supported patients with end-stage heart failure? European Journal of Heart Failure, 7(2), 215-217. (Pubitemid 40215615)
12. Cazeau, S., et al. (2001). Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. The New England Journal of Medicine, 344(12), 873-880. (Pubitemid 32224395)
13. Epstein, A. E., et al. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation, 117(21), e350-e408.
14. Abraham,W. T., et al. (2002). Cardiac resynchronization in chronic heart failure. The New England Journal of Medicine, 346(24), 1845-1853. (Pubitemid 34603028)
15. Cleland, J. G., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New England Journal of Medicine, 352(15), 1539-1549. (Pubitemid 40517094)
16. Bristow, M. R., et al. (2004). Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. The New England Journal of Medicine, 350(21), 2140-2150.
17. van Bommel, R. J., et al. (2010). Effect of cardiac resynchronization therapy in patients with New York Heart Association functional class IV heart failure. The American Journal of Cardiology, 106(8), 1146-1151.
18. Cleland, J., et al. (2008). Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. Journal of the American College of Cardiology, 52(6), 438-445. (Pubitemid 352040815)
19. Linde, C., et al. (2010). Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: Results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study. Journal of the American College of Cardiology, 56(22), 1826-1831.
20. Tang, A. S., et al. (2010). Cardiac-resynchronization therapy for mild-to-moderate heart failure. The New England Journal of Medicine, 363(25), 2385-2395.
21. Dickstein, K., et al. (2010). Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace, 12(11), 1526-1536.
22. Jessup, M., & Brozena, S. (2003). Heart failure. The New England Journal of Medicine, 348(20), 2007-2018.
23. Heiat, A., Gross, C. P., & Krumholz, H. M. (2002). Representation of the elderly, women, and minorities in heart failure clinical trials. Archives of Internal Medicine, 162(15), 1682-1688.
24. Kron, J., et al. (2009). Benefit of cardiac resynchronization in elderly patients: Results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) andMulticenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Journal of Interventional Cardiac Electrophysiology, 25(2), 91-96.
25. Foley, P. W., et al. (2008). Long-term effects of cardiac resynchronization therapy in octogenarians: A comparative study with a younger population. Europace, 10(11), 1302-1307.
26. Delnoy, P. P., et al. (2008). Clinical response of cardiac resynchronization therapy in the elderly. American Heart Journal, 155 (4), 746-751.
27. Antonio, N., et al. (2012). Cardiac resynchronization therapy in the elderly: A realistic option for an increasing population? International Journal of Cardiology, 155(1), 49-51.
28. Blendea, D., et al. (2007). Variability of coronary venous anatomy in patients undergoing cardiac resynchronization therapy: A high-speed rotational venography study. Heart Rhythm, 4(9), 1155-1162. (Pubitemid 47324121)
29. Kannel, W. B., & McGee, D. L. (1979). Diabetes and cardiovascular disease. The Framingham study. Journal of the American Medical Association, 241(19), 2035-2038. (Pubitemid 9228506)
30. Shindler, D. M., et al. (1996). Diabetes mellitus, a predictor of morbidity andmortality in the Studies of LeftVentricularDysfunction (SOLVD) Trials and Registry. The American Journal of Cardiology, 77(11), 1017-1020. (Pubitemid 26158096)
31. Mangiavacchi, M., et al. (2008). Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy. Pacing and Clinical Electrophysiology, 31(11), 1425-1432.
32. Olshansky, B., et al. (2012). Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: An analysis from the COMPANION Trial. Heart Rhythm, 9(1), 34-39.
33. Gervais, R., et al. (2009). Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: A sub-analysis of the CARE-HF trial. European Journal of Heart Failure, 11(7), 699-705.
34. Marcus, G. M. (2012). The PR interval and cardiac resynchronization therapy outcomes: Considering confounding, mediation, and effect modification. Heart Rhythm, 9(1), 40-41.
35. Auricchio, A., et al. (2007). Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. The American Journal of Cardiology, 99(2), 232-238. (Pubitemid 46084859)
36. Sipahi, I., et al. (2011). Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials. Archives of Internal Medicine, 171(16), 1454-1462.
37. Bristow, M. R., Feldman, A. M., & Saxon, L. A. (2000). Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. Journal of Cardiac Failure, 6(3), 276-285.
38. Varma, N. (2009). Left ventricular conduction delays and relation to QRS configuration in patients with left ventricular dysfunction. The American Journal of Cardiology, 103(11), 1578-1585.
39. Bilchick, K. C., et al. (2010). Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients. Circulation, 122(20), 2022-2030.
40. Zareba,W., et al. (2011). Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation, 123(10), 1061-1072.
41. Moss, A. J., et al. (2005). Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): Design and clinical protocol. Annals of Noninvasive Electrocardiology, 10(4 Suppl), 34-43. (Pubitemid 44933552)
42. Auricchio, A., et al. (1999). Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation, 99(23), 2993-3001. (Pubitemid 29270428)
43. Auricchio, A., et al. (2002). Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. Journal of the American College of Cardiology, 39(12), 2026-2033. (Pubitemid 34628286)
44. Leclercq, C., et al. (1998). Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. Journal of the American College of Cardiology, 32(7), 1825-1831. (Pubitemid 29010441)
45. Cazeau, S., et al. (2003). Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: A prospective study. Pacing and Clinical Electrophysiology, 26(1 Pt 2), 137-143. (Pubitemid 36399126)
46. Gorcsan, J., 3rd, et al. (2008). Echocardiography for cardiac resynchronization therapy: Recommendations for performance and reporting-A report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. Journal of the American Society of Echocardiography, 21(3), 191-213. (Pubitemid 351308105)
47. Rouleau, F., et al. (2001). Echocardiographic assessment of the interventricular delay of activation and correlation to the QRS width in dilated cardiomyopathy. Pacing and Clinical Electrophysiology, 24(10), 1500-1506. (Pubitemid 32977308)
48. Ghio, S., et al. (2004). Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. European Heart Journal, 25(7), 571-578. (Pubitemid 38478550)
49. Bordachar, P., et al. (2004). Echocardiographic parameters of ventricular dyssynchrony validation in patients with heart failure using sequential biventricular pacing. Journal of the American College of Cardiology, 44(11), 2157-2165. (Pubitemid 39576035)
50. Achilli, A., et al. (2006). Prediction of response to cardiac resynchronization therapy: The selection of candidates for CRT (SCART) study. Pacing and Clinical Electrophysiology, 29 (Suppl 2), S11-S19. (Pubitemid 44813755)
51. Bax, J. J., et al. (2005). Cardiac resynchronization therapy: Part 1-Issues before device implantation. Journal of the American College of Cardiology, 46(12), 2153-2167. (Pubitemid 41785481)
52. Pitzalis, M. V., et al. (2002). Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. Journal of the American College of Cardiology, 40(9), 1615-1622. (Pubitemid 35253639)
53. Marcus, G. M., et al. (2005). Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. Journal of the American College of Cardiology, 46(12), 2208-2214. (Pubitemid 41785487)
54. Chung, E. S., et al. (2008). Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation, 117(20), 2608-2616.
55. Bax, J. J., & Gorcsan, J., 3rd. (2009). Echocardiography and noninvasive imaging in cardiac resynchronization therapy: Results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. Journal of the American College of Cardiology, 53(21), 1933-1943.
56. Van de Veire, N. R., et al. (2007). Tissue synchronisation imaging accurately measures left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy. Heart, 93(9), 1034-1039. (Pubitemid 47310976)
57. Bax, J. J., et al. (2003). Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with endstage heart failure before pacemaker implantation. The American Journal of Cardiology, 92(10), 1238-1240. (Pubitemid 37377846)
58. Gorcsan, J., 3rd, et al. (2004). Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. The American Journal of Cardiology, 93 (9), 1178-1181. (Pubitemid 38521056)
59. Cannesson, M., et al. (2006). Velocity vector imaging to quantify ventricular dyssynchrony and predict response to cardiac resynchronization therapy. The American Journal of Cardiology, 98(7), 949-953. (Pubitemid 44402275)
60. Bax, J. J., et al. (2004). Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. Journal of the American College of Cardiology, 44(9), 1834- 1840. (Pubitemid 39424084)
61. Yu, C. M., et al. (2004). Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation, 110 (1), 66-73.
62. Van de Veire, N. R., et al. (2007). Usefulness of triplane tissue Doppler imaging to predict acute response to cardiac resynchronization therapy. The American Journal of Cardiology, 100(3), 476-482.
63. Van de Veire, N. R., et al. (2008). Triplane tissue Doppler imaging: A novel three-dimensional imaging modality that predicts reverse left ventricular remodelling after cardiac resynchronisation therapy. Heart, 94(3), e9.
64. Notabartolo, D., et al. (2004). Usefulness of the peak velocity difference by tissue Doppler imaging technique as an effective predictor of response to cardiac resynchronization therapy. The American Journal of Cardiology, 94(6), 817-820. (Pubitemid 39221513)
65. Mele, D., et al. (2006). Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. European Heart Journal, 27 (9), 1070-1078.
66. Miyazaki, C., et al. (2008). Strain dyssynchrony index correlates with improvement in left ventricular volume after cardiac resynchronization therapy better than tissue velocity dyssynchrony indexes. Circulation: Cardiovascular Imaging, 1(1), 14-22.
67. Yu, C. M., et al. (2007). Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. The American Journal of Cardiology, 100(8), 1263-1270.
68. Suffoletto, M. S., et al. (2006). Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation, 113(7), 960-968. (Pubitemid 43879471)
69. Dohi, K., et al. (2005). Utility of echocardiographic radial strain imaging to quantify left ventricular dyssynchrony and predict acute response to cardiac resynchronization therapy. The American Journal of Cardiology, 96(1), 112-116. (Pubitemid 40853953)
70. Marsan, N. A., et al. (2008). Real-time three-dimensional echocardiography permits quantification of left ventricular mechanical dyssynchrony and predicts acute response to cardiac resynchronization therapy. Journal of Cardiovascular Electrophysiology, 19(4), 392-399. (Pubitemid 351457556)
71. Thebault, C., et al. (2011). Real-time three-dimensional speckle tracking echocardiography: A novel technique to quantify global left ventricular mechanical dyssynchrony. European Journal of Echocardiography, 12(1), 26-32.
72. Tanaka, H., et al. (2010). Usefulness of three-dimensional speckle tracking strain to quantify dyssynchrony and the site of latest mechanical activation. The American Journal of Cardiology, 105 (2), 235-242.
73. Truong, Q. A., et al. (2008). Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomography. JACC Cardiovascular Imaging, 1(6), 772-781.
74. Van de Veire, N. R., et al. (2009). The role of non-invasive imaging in patient selection. Europace, 11(suppl 5), v32-v39.
75. Ypenburg, C., et al. (2008). Noninvasive imaging in cardiac resynchronization therapy-Part 1: Selection of patients. Pacing and Clinical Electrophysiology, 31(11), 1475-1499.
76. Abraham, T. P., Dimaano, V. L., & Liang, H. Y. (2007). Role of tissue Doppler and strain echocardiography in current clinical practice. Circulation, 116(22), 2597-2609. (Pubitemid 350179223)
77. Scuteri, L., et al. (2009). Relevance of echocardiographic evaluation of right ventricular function in patients undergoing cardiac resynchronization therapy. Pacing and Clinical Electrophysiology, 32(8), 1040-1049.
78. Shalaby, A., et al. (2008). Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure. The American Journal of Cardiology, 101(2), 238-241.
79. Gradaus, R., et al. (2008). Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy. Heart, 94(8), 1026-1031. (Pubitemid 352039885)
80. Vidal, B., et al. (2006). Relation of response to cardiac resynchronization therapy to left ventricular reverse remodeling. The American Journal of Cardiology, 97(6), 876-881.
81. Verhaert, D., et al. (2010). Long-term reverse remodeling with cardiac resynchronization therapy: Results of extended echocardiographic follow-up. Journal of the American College of Cardiology, 55(17), 1788-1795.
82. Antonio, N., et al. (2009). Identification of 'super-responders' to cardiac resynchronization therapy: The importance of symptom duration and left ventricular geometry. Europace, 11(3), 343-349.
83. Boriani, G., et al. (2012). Impact of mitral regurgitation on the outcome of patients treated with CRT-D: Data from the InSync ICD Italian Registry. Pacing and Clinical Electrophysiology, 35(2), 146-154.
84. Verhaert, D., et al. (2012). Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy. Circulation: Cardiovascular Imaging, 5(1), 21-26.
85. Solis, J., et al. (2009). Mechanism of decrease inmitral regurgitation after cardiac resynchronization therapy: Optimization of the force- balance relationship. Circulation: Cardiovascular Imaging, 2(6), 444-450.
86. van Gelder, B. M., et al. (2005). The hemodynamic effect of intrinsic conduction during left ventricular pacing as compared to biventricular pacing. Journal of the American College of Cardiology, 46(12), 2305-2310. (Pubitemid 41785502)
87. Bleeker, G. B., et al. (2006). Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy. Journal of Cardiovascular Electrophysiology, 17(8), 899-901. (Pubitemid 44079752)
88. Adelstein, E. C., et al. (2011). Impact of scar burden by singlephoton emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. European Heart Journal, 32(1), 93-103.
89. Ypenburg, C., et al. (2007). Effect of total scar burden on contrastenhanced magnetic resonance imaging on response to cardiac resynchronization therapy. The American Journal of Cardiology, 99(5), 657-660.
90. Deedwania, P. C., & Lardizabal, J. A. (2010). Atrial fibrillation in heart failure: A comprehensive review. American Journal of Medicine, 123(3), 198-204.
91. Wilton, S. B., et al. (2011). Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: A systematic review and meta-analysis. Heart Rhythm, 8(7), 1088- 1094.
92. Upadhyay, G. A., et al. (2008). Cardiac resynchronization in patients with atrial fibrillation: A meta-analysis of prospective cohort studies. Journal of the American College of Cardiology, 52(15), 1239-1246.
93. Fumagalli, S., et al. (2011). Comparison of the usefulness of cardiac resynchronization therapy in three age-groups (<65, 65-74 and ≥75 years) (from the InSync/InSync ICD Italian Registry). American Journal of Cardiology, 107(10), 1510-1516.
94. Koplan, B. A., et al. (2009). Heart failure decompensation and allcause mortality in relation to percent biventricular pacing in patients with heart failure: Is a goal of 100% biventricular pacing necessary? Journal of the American College of Cardiology, 53(4), 355-360.
95. Hayes, D. L., et al. (2011). Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm, 8(9), 1469-1475.
96. Butter, C., et al. (2001). Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation, 104(25), 3026-3029. (Pubitemid 34014051)
97. Gold, M. R., et al. (2011). A prospective, randomized comparison of the acute hemodynamic effects of biventricular and left ventricular pacing with cardiac resynchronization therapy. Heart Rhythm, 8(5), 685-691.
98. Wilton, S. B., et al. (2008). Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy. Journal of Interventional Cardiac Electrophysiology, 23(3), 219-227.
99. Singh, O., et al. (2011). Giant renal calculus in a horseshoe kidney presenting as an abdominal lump. Urological Research, 39(6), 503-507.
100. Gold, M. R., et al. (2009). Acute hemodynamic effects of atrial pacing with cardiac resynchronization therapy. Journal of Cardiovascular Electrophysiology, 20(8), 894-900.
101. Khachatryan, V., et al. (2011). Search for stopped Gluinos in pp collisions at square root s07 TeV. Physical Review Letters, 106 (1), 011801.
102. Singh, J. P., et al. (2006). Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm, 3(11), 1285-1292. (Pubitemid 44615674)
103. Heist, E. K., et al. (2005). Radiographic left ventricular-right ventricular interlead distance predicts the acute hemodynamic response to cardiac resynchronization therapy. The American Journal of Cardiology, 96(5), 685-690. (Pubitemid 41207314)
104. Merchant, F.M., et al. (2010). Interlead distance and left ventricular lead electrical delay predict reverse remodeling during cardiac resynchronization therapy. Pacing and Clinical Electrophysiology, 33(5), 575-582.
105. Lambiase, P. D., et al. (2004). Non-contact left ventricular endocardial mapping in cardiac resynchronisation therapy. Heart, 90 (1), 44-51. (Pubitemid 38064542)
106. Rademakers, L. M., et al. (2008). Development of strategies for guiding cardiac resynchronization therapy. Heart Failure Clinics, 4(3), 333-345. (Pubitemid 351885508)
107. Strik, M., et al. (2012) Endocardial left ventricular pacing improves cardiac resynchronization therapy in chronic asynchronous infarction and heart failure models. Circulation: Arrhythmia Electrophysiology, 5, 191-200.
108. Spragg, D. D., et al. (2010). Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy. Journal of the American College of Cardiology, 56(10), 774-781.
109. Haghjoo, M., et al. (2009). Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure. Europace, 11(3), 356-363.
110. Ronn, F., et al. (2011). Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation. Europace, 13(12), 1747- 1752.
111. de Denus, S., et al. (2008). Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring-Further insights from SOLVD. Canadian Journal of Cardiology, 24(1), 45-48.
112. Das, S. R., et al. (2005). Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic heart failure (from the Studies of Left Ventricular Dysfunction Prevention trial). The American Journal of Cardiology, 96(6), 827-831. (Pubitemid 41317660)
113. Parikh, A., et al. (2011). Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: Prevalence and associations with anemia and inflammation. Circulation: Heart Failure, 4(5), 599-606.
114. Felker, G. M., et al. (2004). Anemia as a risk factor and therapeutic target in heart failure. Journal of the American College of Cardiology, 44(5), 959-966. (Pubitemid 39165127)
115. Anker, S. D., et al. (2009). Ferric carboxymaltose in patients with heart failure and iron deficiency. The New England Journal of Medicine, 361(25), 2436-2448.
116. Ezekowitz, J. A., et al. (2011). Trends in heart failure care: Has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? European Journal of Heart Failure, 13(2), 142-147.
117. Cannizzaro, L. A., et al. (2011). Device therapy in heart failure patients with chronic kidney disease. Journal of the American College of Cardiology, 58(9), 889-896.
118. Fruhwald, F. M., et al. (2007). Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. European Heart Journal, 28(13), 1592-1597. (Pubitemid 47227112)
119. Fung, J. W., et al. (2007). Prognostic value of renal function in patients with cardiac resynchronization therapy. International Journal of Cardiology, 122(1), 10-16. (Pubitemid 47503342)
120. Lellouche, N., et al. (2007). Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy. The American Journal of Cardiology, 99(2), 242-246. (Pubitemid 46091658)
121. Lopez-Andres, N., et al. (2012). Association of galectin-3 and fibrosis markers with long-termcardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: Insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. European Journal of Heart Failure, 14(1), 74-81.
122. Magne, J., et al. (2009). Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy. Cardiovascular Ultrasound, 7, 39.
123. Ritter, P., et al. (1999). Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. Europace, 1(2), 126-130.
124. Ypenburg, C., et al. (2008). Noninvasive imaging in cardiac resynchronization therapy-Part 2: Follow-up and optimization of settings. Pacing and Clinical Electrophysiology, 31(12), 1628-1639.
125. Kedia, N., et al. (2006). Usefulness of atrioventricular delay optimization using Doppler assessment of mitral inflow in patients undergoing cardiac resynchronization therapy. The American Journal of Cardiology, 98(6), 780-785. (Pubitemid 44301016)
126. Tournoux, F. B., et al. (2007). Echocardiographic measures of acute haemodynamic response after cardiac resynchronization therapy predict long-term clinical outcome. European Heart Journal, 28(9), 1143-1148. (Pubitemid 47343870)
127. Hardt, S. E., et al. (2007). Immediate and chronic effects of AVdelay optimization in patients with cardiac resynchronization therapy. International Journal of Cardiology, 115(3), 318-325. (Pubitemid 46185632)
128. Ellenbogen, K. A., et al. (2010). Primary results from the Smart- Delay determined AV optimization: A comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: A randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation, 122(25), 2660-2668.
129. Vanderheyden, M., et al. (2005). Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchronization therapy. Heart Rhythm, 2(10), 1066-1072. (Pubitemid 41472153)
130. Sogaard, P., et al. (2002). Sequential versus simultaneous biventricular resynchronization for severe heart failure: Evaluation by tissue Doppler imaging. Circulation, 106(16), 2078-2084. (Pubitemid 35203294)
131. Naqvi, T. Z. (2010). Echocardiography-guided biventricular pacemaker optimization. JACC Cardiovascular Imaging, 3(11), 1168-1180.
132. Rao, R. K., et al. (2007). Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: A randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation, 115(16), 2136-2144. (Pubitemid 46659065)
133. Boriani, G., et al. (2006). Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart FailureManagement II implantable cardioverter defibrillator (RHYTHM II ICD) study. American Heart Journal, 151(5), 1050-1058.
134. Marsan, N. A., et al. (2009). Cardiac resynchronization therapy in patients with ischemic versus non-ischemic heart failure: Differential effect of optimizing interventricular pacing interval. American Heart Journal, 158(5), 769-776.
135. Lozano, I., et al. (2000). Impact of biventricular pacing on mortality in a randomized crossover study of patients with heart failure and ventricular arrhythmias. Pacing and Clinical Electrophysiology, 23(11 Pt 2), 1711-1712.
136. Abraham, W. T., et al. (2004). Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation, 110(18), 2864-2868. (Pubitemid 39473610)
137. Anand, I. S., et al. (2009). Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: Results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation, 119(7), 969-977.
138. Linde, C., et al. (2008). Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. Journal of the American College of Cardiology, 52(23), 1834-1843.
139. Lilli, A., et al. (2007). Cardiac resynchronization therapy: Gender related differences in left ventricular reverse remodeling. Pacing and Clinical Electrophysiology, 30(11), 1349- 1355. (Pubitemid 350043826)
140. Zardkoohi, O., et al. (2007). The impact of age and gender on cardiac resynchronization therapy outcome. Pacing and Clinical Electrophysiology, 30(11), 1344-1348. (Pubitemid 350043825)
141. Bleeker, G. B., et al. (2005). Does a gender difference in response to cardiac resynchronization therapy exist? Pacing and Clinical Electrophysiology, 28(12), 1271-1275. (Pubitemid 43951386)